Pyxis Oncology (PYXS) Institutional Ownership $3.82 -0.34 (-8.17%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Pyxis Oncology (NASDAQ:PYXS)CurrentInstitutional OwnershipPercentage39.09%Number ofInstitutional Buyers(last 12 months)30TotalInstitutional Inflows(last 12 months)$30.70MNumber ofInstitutional Sellers(last 12 months)6TotalInstitutional Outflows(last 12 months)$960.33K Get PYXS Insider Trade Alerts Want to know when executives and insiders are buying or selling Pyxis Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PYXS Institutional Buying and Selling by Quarter Ad Wyatt Investment ResearchMy #1 Pre IPO Trade for 2025 – NAME and TICKEROne tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report...The Next SpaceX Pre-IPO Pyxis Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC64,089$235K0.0%+275.0%0.108% 11/16/2024 Geode Capital Management LLC1,084,727$3.98M0.0%+5.5%1.824% 11/15/2024 Barclays PLC64,089$235K0.0%+275.0%0.108% 11/15/2024 Public Employees Retirement System of Ohio29,100$107K0.0%N/A0.049% 11/15/2024 XTX Topco Ltd84,771$311K0.0%+133.6%0.143% 11/15/2024 Jane Street Group LLC49,558$182K0.0%+40.8%0.083% Get the Latest News and Ratings for PYXS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pyxis Oncology and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 State Street Corp951,251$3.49M0.0%+28.0%1.600% 11/15/2024 Jacobs Levy Equity Management Inc.382,840$1.41M0.0%N/A0.644% 11/14/2024 MetLife Investment Management LLC18,818$69K0.0%+41.1%0.032% 11/9/2024 Intech Investment Management LLC14,897$55K0.0%N/A0.025% 11/7/2024 LMR Partners LLP80,000$294K0.0%N/A0.135% 11/6/2024 Schulhoff & Co. Inc.122,000$448K0.2%+190.5%0.205% 11/6/2024 Pier 88 Investment Partners LLC121,610$446K0.1%+7.0%0.205% 10/25/2024 abrdn plc913,045$3.35M0.0%+28.9%1.537% 10/3/2024 SG Americas Securities LLC15,800$58K0.0%N/A0.027% 8/15/2024Susquehanna Fundamental Investments LLC57,025$189K0.0%-30.8%0.097% 8/15/2024 Blue Owl Capital Holdings LP1,046,025$3.46M1.0%N/A1.776% 8/15/2024 The Manufacturers Life Insurance Company19,730$65K0.0%N/A0.034% 8/15/2024 Millennium Management LLC1,336,908$4.43M0.0%+125.3%2.270% 8/14/2024 Marshall Wace LLP10,000$33K0.0%-92.5%0.017% 8/12/2024 XTX Topco Ltd36,290$120K0.0%-44.9%0.062% 8/12/2024 Marathon Trading Investment Management LLC16,380$54K0.0%-71.3%0.028% 8/9/2024 Renaissance Technologies LLC96,936$321K0.0%-34.5%0.165% 8/9/2024 Dimensional Fund Advisors LP81,934$271K0.0%-19.5%0.139% 8/8/2024 Schulhoff & Co. Inc.42,000$139K0.1%+90.9%0.071% 8/8/2024 American Century Companies Inc.58,252$193K0.0%+56.0%0.099% 8/6/2024 Pier 88 Investment Partners LLC113,700$376K0.1%+121.4%0.193% 8/1/2024 Rhumbline Advisers65,287$216K0.0%N/A0.111% 7/26/2024 Bank of New York Mellon Corp311,630$1.03M0.0%+92.2%0.529% 7/25/2024 Fullcircle Wealth LLC12,000$40K0.0%N/A0.020% 5/24/2024Cetera Advisors LLC23,500$100K0.0%N/A0.040% 5/17/2024 Ikarian Capital LLC1,662,408$7.08M0.8%N/A2.823% 5/14/2024 StemPoint Capital LP1,794,195$7.64M2.0%N/A3.047% 5/10/2024 Vanguard Group Inc.1,401,425$5.97M0.0%+7.3%2.380% 5/7/2024Susquehanna Fundamental Investments LLC82,447$351K0.0%N/A0.140% 5/7/2024 SG Americas Securities LLC13,809$59K0.0%N/A0.023% 2/20/2024 Cable Car Capital LLC61,606$111K0.1%N/A0.139% 2/14/2024 Vestal Point Capital LP440,000$792K0.1%N/A0.993% 2/12/2024 Decheng Capital LLC326,810$588K0.2%N/A0.737% 1/31/2024 abrdn plc708,303$1.28M0.0%N/A1.598% 2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!]11/29/2023Decheng Capital Management III Cayman LLC326,810$650K0.2%N/A0.737% 11/15/2023 Radcliffe Capital Management L.P.53,288$106K0.0%N/A0.120% 11/14/2023 Schulhoff & Co. Inc.22,000$44K0.0%N/A0.050% 11/13/2023 Acadian Asset Management LLC13,233$26K0.0%N/A0.030% 10/23/2023Commonwealth Equity Services LLC12,950$26K0.0%N/A0.033% 8/14/2023 Prelude Capital Management LLC10,352$27K0.0%N/A0.027% 8/11/2023 Harvest Investment Services LLC116,428$298K0.2%+27.9%0.304% 8/11/2023 ExodusPoint Capital Management LP259,561$664K0.0%+270.8%0.679% 8/10/2023 Cetera Investment Advisers18,260$47K0.0%N/A0.048% 7/10/2023 SG Americas Securities LLC20,497$52K0.0%N/A0.054% 5/16/2023 Hhlr Advisors LTD.530,692$2.13M0.0%-30.6%1.435% 5/4/2023 Barclays PLC118,223$474K0.0%-87.5%0.320% 4/27/2023Simplicity Solutions LLC18,110$73K0.0%N/A0.049% 2/15/2023 Tang Capital Management LLC3,470,700$4.65M0.7%+145.9%9.888% 2/9/2023 Citigroup Inc.357,537$479K0.0%+14.5%1.019% 1/12/2023 Marquette Asset Management LLC58,862$79K0.0%N/A0.168% 11/15/2022 Tang Capital Management LLC1,411,569$2.78M0.3%+2.4%4.022% 11/14/2022 RA Capital Management L.P.764,653$1.51M0.0%-19.8%2.179% 8/15/2022 Acuta Capital Partners LLC645,149$1.54M0.9%+222.6%1.966% 8/15/2022 Laurion Capital Management LP3,170,803$7.55M0.1%+159.9%9.662% 5/16/2022 Ghost Tree Capital LLC75,000$303K0.1%-74.6%0.228% 5/13/2022Tekla Capital Management LLC708,303$2.63M0.1%+424.7%2.157% 2/16/2022 Ghost Tree Capital LLC295,000$3.24M1.2%N/A0.900% 2/15/2022 Laurion Capital Management LP1,162,332$12.75M0.1%N/A3.548% 2/15/2022 Davidson Kempner Capital Management LP10,000$109K0.0%N/A0.031% 2/14/2022 Citadel Advisors LLC1,521,617$16.48M0.0%N/A4.644% 2/14/2022 Deerfield Management Company L.P. Series C311,754$3.42M0.1%N/A0.952% 2/14/2022 Hhlr Advisors LTD.764,406$8.39M0.1%N/A2.333% 2/14/2022 Perceptive Advisors LLC1,944,114$21.33M0.3%N/A5.934% 2/14/2022 Sandia Investment Management LP10,000$110K0.0%N/A0.031% 2/14/2022 Ghisallo Capital Management LLC30,000$329K0.0%N/A0.092% 2/8/2022 Northern Trust Corp89,235$979K0.0%N/A0.272% 2/2/2022 New York State Common Retirement Fund6,277$69K0.0%N/A0.019% (Data available from 1/1/2016 forward) PYXS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PYXS shares? During the previous two years, 46 institutional investors and hedge funds held shares of Pyxis Oncology. The most heavily invested institutionals were StemPoint Capital LP ($7.64M), Ikarian Capital LLC ($7.08M), Vanguard Group Inc. ($5.97M), Tang Capital Management LLC ($4.65M), Millennium Management LLC ($4.43M), Geode Capital Management LLC ($3.98M), and State Street Corp ($3.49M).Learn more on PYXS's institutional investors. What percentage of Pyxis Oncology stock is owned by institutional investors? 39.09% of Pyxis Oncology stock is owned by institutional investors. Learn more on PYXS's institutional investor holdings. Which institutional investors have been buying Pyxis Oncology stock? Of the 41 institutional investors that purchased Pyxis Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Tang Capital Management LLC ($2.06M), StemPoint Capital LP ($1.79M), Ikarian Capital LLC ($1.66M), Blue Owl Capital Holdings LP ($1.05M), abrdn plc ($913.05K), Millennium Management LLC ($743.50K), and Vestal Point Capital LP ($440K). How much institutional buying is happening at Pyxis Oncology? Institutional investors have bought a total of 11,463,743 shares in the last 24 months. This purchase volume represents approximately $34.55M in transactions. Which Pyxis Oncology major shareholders have been selling company stock? The following institutional investors have sold Pyxis Oncology stock in the last 24 months: Barclays PLC ($829.83K), Hhlr Advisors LTD. ($233.71K), Marshall Wace LLP ($123.58K), Renaissance Technologies LLC ($51.06K), Marathon Trading Investment Management LLC ($40.62K), XTX Topco Ltd ($29.57K), and Susquehanna Fundamental Investments LLC ($25.42K). How much institutional selling is happening at Pyxis Oncology? Institutional investors have sold a total of 1,353,672 shares in the last 24 months. This volume of shares sold represents approximately $5.23M in transactions. Related Companies MGNX Major Shareholders ADCT Major Shareholders RANI Major Shareholders ACET Major Shareholders STTK Major Shareholders PASG Major Shareholders BCYC Major Shareholders PAHC Major Shareholders COLL Major Shareholders IMTX Major Shareholders This page (NASDAQ:PYXS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pyxis Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pyxis Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PYXS Stock Alerts